Histone Deacetylase 3 Interacts with and Deacetylates Myocyte Enhancer Factor 2

Grégoire, Serge, Xiao, Lin, Nie, Jianyun, Zhang, Xiaohong, Xu, Minghong, Li, Jiarong, Wong, Jiemin, Seto, Edward +1 more·2007·Molecular and Cellular Biology
DOI 10.1128/mcb.00882-06

Cited by (204)

Items 101–200 of 204

  1. Histone deacetylases and repression of the gonadotropin genes
    Philippa Melamed · 2008 · Trends in Endocrinology and Metabolism
  2. Association of two BRM promoter polymorphisms with head and neck squamous cell carcinoma risk
    Jennifer Rui Wang, Sarah J.B. Gramling, David Paul Goldstein, Dangxiao Cheng, Duoduo Chen, Abul Kalam Azad, Alvina Tse, Henrique Hon, Zhuo Chen, Maryam Mirshams et al. · 2013 · Carcinogenesis
  3. Exercise increases the binding of MEF 2A to the Cpt1b promoter in mouse skeletal muscle
    Hairui Yuan, Yanmei Niu, Xin Liu, Li Fu · 2014 · Acta Physiologica
  4. Structural functionality of skeletal muscle mitochondria and its correlation with metabolic diseases
    Gourabamani Swalsingh, Punyadhara Pani, Naresh Chandra Bal · 2022 · Clinical Science
  5. Histone deacetylase 3 (HDAC3) as an important epigenetic regulator of kidney diseases
    Lijun Zhang, Wangsen Cao · 2021 · Journal of Molecular Medicine
  6. Inhibition of Glyceroneogenesis by Histone Deacetylase 3 Contributes to Lipodystrophy in Mice with Adipose Tissue Inflammation
    Jin Zhang, Tara M. Henagan, Zhan‐Guo Gao, Jianping Ye · 2011 · Endocrinology
  7. Nuclear receptor corepressors in intellectual disability and autism
    Yan Kong, Wenjun Zhou, Zheng Sun · 2020 · Molecular Psychiatry
  8. Role of Histone Deacetylases in Skeletal Muscle Physiology and Systemic Energy Homeostasis: Implications for Metabolic Diseases and Therapy
    Haili Tian, Sujuan Liu, Jun Tao Ren, JASON KAI WEI LEE, Ru Wang, Peijie Chen · 2020 · Frontiers in Physiology
  9. Non-histone substrates of histone deacetylases as potential therapeutic targets in epilepsy
    Sonali Kumar, Diksha Attrish, Arpna Srivastava, Jyotirmoy Banerjee, Manjari Tripathi, Poodipedi Sarat Chandra, Aparna Banerjee Dixit · 2020 · Expert Opinion on Therapeutic Targets
  10. HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy
    Jie Wang, Feng Yun, Jiahui Sui, Wenpeng Liang, Dingding Shen, Qi Zhang · 2022 · Biomedicines
  11. Homeodomain-interacting protein kinase 2-dependent repression of myogenic differentiation is relieved by its caspase-mediated cleavage
    Laureano de la Vega, Juliane Hornung, Elisabeth Kremmer, Maja Milanovic, Michael Lienhard Schmitz · 2013 · Nucleic Acids Research
  12. Histone Deacetylase 3 Governs Perinatal Cerebral Development via Neural Stem and Progenitor Cells
    Lin Li, Jianliang Jin, Xiang‐Jiao Yang · 2019 · iScience
  13. Transcriptomic and genomic studies classify NKL54 as a histone deacetylase inhibitor with indirect influence on MEF2-dependent transcription
    Minisini, Martina, Di Giorgio, Eros, Kerschbamer, Emanuela, Dalla, Emiliano, Faggiani, Massimo, Franforte, Elisa, Meyer-Almes, Franz-Josef, Ragno, Rino, Antonini, Lorenzo, Mai, Antonello et al. · 2022 · Nucleic Acids Research
  14. Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer
    Milan Beljkaš, Aleksandra Ilić, Alen Čebzan, B. Radović, Nemanja Djoković, Dušan Ružić, Katarina M. Nikolic, Slavica Oljačić · 2023 · Pharmaceutics
  15. Aldose Reductase Acts as a Selective Derepressor of PPARγ and the Retinoic Acid Receptor
    Devi Thiagarajan, Radha Ananthakrishnan, Jinghua Zhang, Karen M. O’Shea, Nosirudeen Quadri, Qing Li, Kelli Margot Sas, Jing Xiao, Rosa Rosario, Subramaniam Pennathur et al. · 2016 · Cell Reports
  16. It is a complex issue: emerging connections between epigenetic regulators in drug addiction
    Ethan M. Anderson, Rachel D. Penrod, Sarah M. Barry, Brandon W. Hughes, Makoto Taniguchi, Christopher W. Cowan · 2018 · European Journal of Neuroscience
  17. Cisplatin induces Sirt1 in association with histone deacetylation and increased Werner syndrome protein in the kidney
    Yukitoshi Sakao, Akihiko Kato, Takayuki Tsuji, Hideo Yasuda, Akashi Togawa, Yoshihide Fujigaki, Tomoaki Kahyo, Mitsutoshi Setou, Akira Hishida · 2011 · Clinical and Experimental Nephrology
  18. Rational Design of Substrate‐Based Multivalent Inhibitors of the Histone Acetyltransferase Tip60
    Chao Yang, Liza Ngo, Y. George Zheng · 2014 · ChemMedChem
  19. Myocyte enhancer factor 2 (MEF2) tethering to muscle selective A-kinase anchoring protein (mAKAP) is necessary for myogenic differentiation
    Maximilian A.X. Vargas, Jennifer S. Tirnauer, Nicole C. Glidden, Michael S. Kapiloff, Kimberly L. Dodge‐Kafka · 2012 · Cellular Signalling
  20. The lysine methyltransferase SMYD2 facilitates neointimal hyperplasia by regulating the HDAC3–SRF axis
    Xiaoxuan Zhong, Wei Xiang, Yan Hua Xu, Xue‐Hai Zhu, Bo Huo, Xian Guo, Gaoke Feng, Zihao Zhang, Xin Feng, Zemin Fang et al. · 2023 · Acta Pharmaceutica Sinica B
  21. A study of the role of the myocyte-specific enhancer factor-2A gene in coronary artery disease
    Samar Elhawari, Olyan M. Al-Boudari, Paul Muiya, Hanif G. Khalak, Editha Andres, Maie Alshahid, Mohammed Salem Al-Dosari, Brian F. Meyer, Futwan A Al-Mohanna, Nduna Dzimiri · 2009 · Atherosclerosis
  22. Protein acetylation mechanisms in the regulation of insulin and insulin-like growth factor 1 signalling
    Luciano Pirola, Ouafa Zerzaihi, Hubert Vidal, Florence Solari · 2012 · Molecular and Cellular Endocrinology
  23. Myocyte Enhancer Factor 2A Plays a Central Role in the Regulatory Networks of Cellular Physiopathology
    Benrong Liu, Wenchao Ou, Lei Fang, Chaowei Tian, Yujuan Xiong · 2022 · Aging and Disease
  24. The Two Faces of HDAC3: Neuroinflammation in Disease and Neuroprotection in Recovery
    Cal Rosete, Annie Vogel Ciernia · 2024 · Epigenomics
  25. MEF-2 isoforms' (A-D) roles in development and tumorigenesis
    Kiran Madugula, Ria Mulherkar, Zafar K. Khan, DeGaulle I. Chigbu, Dip Patel, Edward William Harhaj, Pooja Jain · 2019 · Oncotarget
  26. Critical review of non‐histone human substrates of metal‐dependent lysine deacetylases
    Tasha B. Toro, Terry J. Watt · 2020 · The FASEB Journal
  27. An acetylation rheostat for the control of muscle energy homeostasis
    Keir J. Menzies, Johan H. Auwerx · 2013 · Journal of Molecular Endocrinology
  28. Epigenetic dynamics of the thermogenic gene program of adipocytes
    Danielle Yi, Hai P. Nguyen, Hei Sook Sul · 2020 · Biochemical Journal
  29. MEF2D expression increases during neuronal differentiation of neural progenitor cells and correlates with neurite length.
    B. Lam, Sangeeta Chawla · 2007 · Neuroscience Letters
  30. Discovery of Novel HDAC3 Inhibitors with PD-L1 Downregulating/Degrading and Antitumor Immune Effects
    Zhiqiang Sun, Chenglong Xu, Jinmei Cheng, Zichao Yang, Ting Liu, Bulian Deng, Xuewen Zhang, Xiaopeng Peng, Jianjun Chen · 2024 · Journal of Medicinal Chemistry
  31. Adenosine Monophosphate–Activated Protein Kinase-α2 Deficiency Promotes Vascular Smooth Muscle Cell Migration via S-Phase Kinase–Associated Protein 2 Upregulation and E-Cadherin Downregulation
    Ping Song, Yanhong Zhou, Kathleen A. Coughlan, Xiaoyan Dai, Hairong Xu, Benoı̂t Viollet, Ming‐Hui Zou · 2013 · Arteriosclerosis Thrombosis and Vascular Biology · Retracted
  32. Targeting histone deacetylases: A novel therapeutic strategy for atrial fibrillation
    Baigalmaa Lkhagva, Yu‐Hsun Kao, Yao‐Chang Chen, Tze‐Fan Chao, Shih-Ann Chen, Yi‐Jen Chen · 2016 · European Journal of Pharmacology
  33. HDAC3 as a Molecular Chaperone for Shuttling Phosphorylated TR2 to PML: A Novel Deacetylase Activity-Independent Function of HDAC3
    Pawan Kumar Gupta, Ping‐Chih Ho, Sung Gil Ha, Yi-Wei Lin, Li‐Na Wei · 2009 · PLoS ONE
  34. Transcriptional Analysis of the Human Cardiac Calsequestrin Gene in Cardiac and Skeletal Myocytes
    José Luís Reyes-Juárez, Raúl Juárez-Rubí, Gabriela Rodrı́guez, Ángel Zarain‐Herzberg · 2007 · Journal of Biological Chemistry
  35. The Role of Transcription Factors in Coronary Artery Disease and Myocardial Infarction
    Chunyan Luo, Yuwen Ruan, Peixue Sun, Haoran Wang, Weihua Yang, Yuankai Gong, Decheng Wang · 2022 · Frontiers in Bioscience-Landmark
  36. Muscle A-kinase–anchoring protein-β–bound calcineurin toggles active and repressive transcriptional complexes of myocyte enhancer factor 2D
    Jinliang Li, Shania Aponte París, Hrishikesh Singh Thakur, Michael S. Kapiloff, Kimberly L. Dodge‐Kafka · 2018 · Journal of Biological Chemistry
  37. Histone deacetylase 3 is required for development and metamorphosis in the red flour beetle, Tribolium castaneum
    Smitha George, Subba Reddy Palli · 2020 · BMC Genomics
  38. Effects of mineral methionine hydroxy analog chelate in sow diets on epigenetic modification and growth of progeny
    Ki Beom Jang, Jong Hyuk Kim, Jerry M Purvis, Juxing Chen, Ping Ren, Mercedes Vazquez-Anon, Sung Woo Kim · 2020 · Journal of Animal Science
  39. Discovery of BRM Targeted Therapies: Novel Reactivation of an Anticancer Gene
    Sarah J.B. Gramling, David Reisman · 2010 · Letters in Drug Design & Discovery
  40. Tapping the brake on cardiac growth-endogenous repressors of hypertrophic signaling-
    Joost J. Leenders, Yigal M. Pinto, Esther E. Creemers · 2011 · Journal of Molecular and Cellular Cardiology
  41. Sumoylation in Development and Differentiation
    Adeline F. Deyrieux, Van G. Wilson · 2017 · Advances in experimental medicine and biology
  42. CAPE increases the expression of SOD3 through epigenetics in human retinal endothelial cells
    Atsuko Ohashi, Hiroyuki Yasuda, Tetsuro Kamiya, Hirokazu Hara, Tetsuo Adachi · 2017 · Journal of Clinical Biochemistry and Nutrition
  43. Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells
    Giuseppe Damante · 2010 · Oncology Reports
  44. Transcriptional Regulation by Nuclear Corepressors and PGC-1α: Implications for Mitochondrial Quality Control and Insulin Sensitivity
    Zhengtang Qi, Shuzhe Ding · 2012 · PPAR Research
  45. Dissecting HDAC3-mediated tumor progression
    John Martin Mariadason · 2008 · Cancer Biology & Therapy
  46. Associations of genetic variants in the transcriptional coactivators EP300 and PCAF with hepatocellular carcinoma.
    Abdellah Akil, S. Ezzikouri, A. E. El Feydi, M. Benazzouz, R. Afifi, A. Diagne, A. Benjouad, A. Dejean, P. Pineau, S. Benjelloun · 2012 · Cancer Epidemiology
  47. Currying favor for the heart
    Jonathan A. Epstein · 2008 · Journal of Clinical Investigation
  48. The Expression and Localization of Histone Acetyltransferases HAT1 and PCAF in Neurons and Astrocytes of the Photothrombotic Stroke-Induced Penumbra in the Rat Brain Cortex
    Svetlana Viktorovna Demyanenko, Valentina Dzreyan, Anatoly B. Uzdensky · 2020 · Molecular Neurobiology
  49. Histone Deacetylase 3 Promotes RCAN1 Stability and Nuclear Translocation
    Kyung Ah Han, Hye Seon Kang, Jee Won Lee, Lang Yoo, Eunju Im, Ahyoung Hong, Yun Ju Lee, Woo Hyun Shin, Kwang Chul Chung · 2014 · PLoS ONE
  50. The MEF2A and MEF2D function as scaffold proteins that interact with HDAC1 or p300 in SOD3 expression in THP-1 cells
    Mari Ichihara, Tetsuro Kamiya, Hirokazu Hara, Tetsuo Adachi · 2018 · Free Radical Research
  51. In Cortical Neurons HDAC3 Activity Suppresses RD4-Dependent SMRT Export
    Francesc Xavier Soriano, Giles E. Hardingham · 2011 · PLoS ONE
  52. Bisphenol S reduces locomotor performance and modifies muscle protein levels but not mitochondrial bioenergetics in adult zebrafish
    Tiana Pelaia, Alexander M. Rubin, Frank Seebacher · 2023 · Aquatic Toxicology
  53. Heart failure: The pivotal role of histone deacetylases
    Ruth Hewitson, James Dargan, David Collis, Aneta Green, Narain Moorjani, Sunil Kumar Ohri, Paul A. Townsend · 2012 · The International Journal of Biochemistry & Cell Biology
  54. Mitotic Activation of a Novel Histone Deacetylase 3-Linker Histone H1.3 Protein Complex by Protein Kinase CK2
    Hemangi Patil, Carrie Wilks, Rhiannon W. Gonzalez, Sudheer Dhanireddy, Heather Conrad-Webb, Michael Bergel · 2015 · Journal of Biological Chemistry
  55. 5 Histone Deacetylase Inhibitors: A Novel Class of Anti-Cancer Agents on its Way to the Market
    Matthias Körner, Ulrich Tibes · 2008 · Progress in medicinal chemistry
  56. HDACs and Their Inhibitors on Post-Translational Modifications: The Regulation of Cardiovascular Disease
    Siyi Yang, Yidong Sun, Wei Yu · 2025 · Cells
  57. The role of MEF2 transcription factors in dehydration and anoxia survival inRana sylvaticaskeletal muscle
    Myriam P Hoyeck, Hanane Hadj‐Moussa, Kenneth B. Storey · 2017 · PeerJ
  58. FcεRI-HDAC3-MCP1 Signaling Axis Promotes Passive Anaphylaxis Mediated by Cellular Interactions
    Mi-Sun Kim, Yoojung Kwon, Hyun Suk Jung, Youngmi Kim, Dooil Jeoung · 2019 · International Journal of Molecular Sciences
  59. Enhancer of Zeste Homolog 2 (EZH2) Mediates Glucolipotoxicity-Induced Apoptosis in β-Cells
    Tina Dahlby, Christian Simon, Marie Balslev Backe, Mattias Salling Dahllöf, Edward B. Holson, Bridget K. Wagner, Marianne Böni‐Schnetzler, Michał Marzec, Morten Lundh, Thomas R Mandrup-Poulsen · 2020 · International Journal of Molecular Sciences
  60. Andrographolide Inhibits Lytic Reactivation of Epstein-Barr Virus by Modulating Transcription Factors in Gastric Cancer
    Praphatson Malat, Tipaya Ekalaksananan, Chukkris Heawchaiyaphum, Supawadee Suebsasana, Sittiruk Roytrakul, Yodying Yingchutrakul, Chamsai Pientong · 2021 · Microorganisms
  61. Lysine acetyltransferases cyclic adenosine monophosphate response element‐binding binding protein and acetyltransferase p300 attenuate transcriptional activity of the mineralocorticoid receptor through its acetylation
    Minchul Seo, Min‐Ji Song, Young Mi Seok, Seol Hee Kang, Hae Ahm Lee, Uy Dong Sohn, In Kyeom Kim · 2015 · Clinical and Experimental Pharmacology and Physiology
  62. HDACs in Skeletal Muscle Remodeling and Neuromuscular Disease
    Bryan J. Simmons, Todd J. Cohen, Richard Bedlack, Tso‐Pang Yao · 2011 · Handbook of experimental pharmacology
  63. HDAC3 and HDAC8 are required for cilia assembly and elongation
    Seon-Ah Park, Hyunjeong Yoo, Jae Hong Seol, Kunsoo Rhee · 2019 · Biology Open
  64. Deacetylation of ATG16L1 is required for LC3-associated lysosomal microautophagy
    Qian Wang, Wei Wan, Hongtao Zhang, Tianhua Zhou, Han‐Ming Shen, Pingtong Huang, Wei Liu · 2025 · Autophagy
  65. Small Changes, Big Effects: Chromatin Goes Aging
    Asmitha Lazarus, Kushal K. Banerjee, Ullas Kolthur‐Seetharam · 2012 · Sub-cellular biochemistry/Subcellular biochemistry
  66. Determination of Protein Lysine Deacetylation
    Danielle J.P. Ellis, Zhigang Yuan, Edward Seto · 2008 · Current Protocols in Protein Science
  67. Assays for Acetylation and Other Acylations of Lysine Residues
    Nadine Pelletier, Serge Grégoire, Xiang‐Jiao Yang · 2017 · Current Protocols in Protein Science
  68. Characterization of molecular interactions between HDAC7 and MEF2A
    Narayan Gautam, Prem P. Chapagain, Narayan Prasad Adhikari, Purushottam Babu Tiwari · 2024 · Journal of Biomolecular Structure and Dynamics
  69. The Role of HATs and HDACs in Cell Physiology and Disease
    Irene Santos‐Barriopedro, Helena Raurell‐Vila, Alejandro Vaquero · 2017 · Wiley eBooks
  70. The advances in acetylation modification in senescence and aging-related diseases
    Maiqi Xu, Wenbin Wang, Saien Lu, Mengyao Xiong, Tong Zhao, Yao Yu, Chunyu Song, Jinjing Yang, Naijin Zhang, Liu Cao et al. · 2025 · Frontiers in Physiology
  71. DEHP and Its Metabolite MEHP Alter the Insr and Glut4 Gene Expression by Blunting the Interaction of Transcription Factors in L6 Myotubes
    Mangala Priya Viswanathan, Vigneswari Mullainadhan, Balasubramanian Karundevi · 2024 · International Journal of Toxicology
  72. BRM promoter insertion polymorphisms increase the risk of cancer: A meta-analysis
    Xi Ouyang, Xiao long Ye, Hong bo Wei · 2017 · Gene
  73. Analysis of Protein Lysine Acetylation In Vitro and In Vivo
    Nadine Pelletier, Serge Grégoire, Xiang‐Jiao Yang · 2008 · Current Protocols in Protein Science
  74. Reactivation of Epstein-Barr virus lytic cycle by histone deacetylase inhibitors
    Hui, KF, Chiang, AKS · 2015 · Cancer Cell & Microenvironment
  75. MEF2D Aggravates Hepatic Ischaemia–Reperfusion Injury by Transcriptionally Regulating CXCL1 Through Interacting With NAT10
    Zhigao Deng, Zhongshan Lu, Quanwei Cheng, Liyang Pan, Lihua Zhou, Wei Zhou, Chengbiao Xue, Zhongzhong Liu, Qifa Ye, Rui Zhou et al. · 2025 · Liver International
  76. Sumoylation in Development and Differentiation
    Adeline F. Deyrieux, Van G. Wilson · 2009 · Springer eBooks
  77. MEF2D regulates T-cell function via CD70-CD27 signaling and promotes immune evasion in hepatocellular carcinoma
    Fanhua Kong, Liqing Wang, Zhongshan Lu, Jiakang Zhou, Qifa Ye, Wayne W. Hancock, Yan Xiong · 2025 · The Journal of Immunology
  78. Histone Deacetylase Functions in Epidermal Development, Homeostasis and Cancer
    Donna M. Brennan-Crispi, Sarah E. Millar · 2018 · Contributions to management science
  79. Transcription Factors
    KE Hauschild, CD Carlson, LJ Donato, Rocco Moretti, AZ Ansari · 2008 · Wiley Encyclopedia of Chemical Biology
  80. The role of class I histone deacetylases in cardiac development of chicken embryos
    Claudia Engelmaier · 2011 · University of Vienna
  81. Molecular Mechanisms of the Transcriptional co-activator Mastermind-Like 1
    Magnus L. Hansson · 2010 · Figshare
  82. Corepressors in Mediating Repression by Nuclear Receptors
    Gratien G. Préfontaine, Peter J. Cook, Michael G. Rosenfeld · 2010 · Elsevier eBooks
  83. Epigenetics in Skeletal Muscle Development
    Cristina Giacinti, Antonio Giordano · 2011
  84. PCAF lysine acetyltransferase
    Cindy Degerny, Nadine Pelletier, Xiang‐Jiao Yang · 2008 · AfCS-Nature Molecule Pages
  85. Conservation across species identifies several transcriptional enhancers in the HEX genomic region
    Angela Valentina D'Elia, Elisa Bregant, Nadia Passon, Cinzia Puppin, Alessia Meneghel, Giuseppe Damante · 2009 · Molecular and Cellular Biochemistry
  86. Discovery of BRM Promoter Polymorphisms: Importance in Risk Stratification and Clinical Application
    Stefanie B. Marquez · 2014 · Postdoc Journal
  87. Nuclear Corepressors and PGC-1α: Implications for Mitochondrial Quality Control and Insulin Sensitivity
    Zhengtang Qi, Shuzhe Ding · 2012
  88. Histone deacetylases and autosomal dominant polycystic kidney disease
    Cheng Xue, Changlin Mei · 2011 · Academic Journal of Second Military Medical University
  89. Epigenesis in Colorectal Cancer: A Lethal Change in the Cell
    Rashmi K. Ambasta, Dhiraj Kumar, Piyush Sawhney, Rajat Gupta, Parul Yadav, Pooja Pabari, Pravir Kumar · 2016 · Springer eBooks
  90. Histone Deacetylase 3 Coordinates Heart Development Through Stage-Specific Roles in Cardiac Progenitor Cells
    Sara L. Lewandowski · 2016 · eScholarship@UMassChan
  91. The Interaction of Early Growth Response Gene 1 and Myocyte Enhancer Factor 2C in the Murine Brain Cortex
    Alexander Murray · 2021 · VTechWorks (Virginia Tech)
  92. Immunohistochemical Studies on HDAC-4 in Experimentally Induced Parkinson's Diseases
    Mohamed Ahmed Akela, Saber A. Sakr, Wafaa M. Ebrahim, Ahmed A. Massoud, Ehab Tousson, Abdulaziz A. Akila · 2015 · American Journal of Biology and Life Sciences
  93. Histone Deacetylases (HDACs) as Key Targets in Metabolic Disorders
    Mohammed Mukhtar Yusif · 2024 · IntechOpen eBooks
  94. Decoding the role of glucocorticoid-regulated kinase 1 in Alzheimer's disease: a promising path toward novel therapeutic strategies
    Yukti Mittal, Pankaj Kumar, Kajal Joshi, Khadga Raj Aran · 2025 · Inflammopharmacology
  95. Zinc-Dependent Histone Deacetylase (HDAC) Inhibitors: Therapeutic Potential, Pharmacophore Structure, and Methods for Testing Deacylase Activity
    Anastasia S. Zemskaya, Sergey N. Kochetkov, Maxim V. Kozlov · 2025 · Molecular Biology
  96. Chromatin regulators and transcriptional control of Drosophila development
    Qi Dai · 2007 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  97. Transcription Factor Acetylation and Cell Fate Control: A Molecular Switch in Hematopoiesis and Myogenesis
    Pegah Ghavidel, Yassine Abdelmalki, Marie‐Claude Sincennes · 2026 · Frontiers in Bioscience-Landmark
  98. The Diverse Roles of the MEF2 Transcription Factor Family in Tumor Progression and Emerging Therapeutic Opportunities
    Yanyan Chen, Jingni Zhu, Jinghang Qian, Sheng Li, Yang Liu · 2026 · Biomedicines
  99. BindingDB Entry 50021384: Discovery of Novel HDAC3 Inhibitors with PD-L1 Downregulating/Degrading and Antitumor Immune Effects.
    BindingDB · 2025 · UC San Diego
  100. BindingDB Entry 50038599: Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases.
    BindingDB · 2012 · UC San Diego